[1] Bourreillee J, Metayer P, Sauger F, et al. Existence d’alpha foetoproteine au cours d’un cancer secondaire du foie d’origine gastrique[J]. Press Med, 1970, 78: 1277-8. [2] Inagawa S, Shimazaki J, Hori M, et al. Hepatoid adenocarcinoma of the stomach[J]. Gastric Cancer, 2001, 4(1): 43-52. [3] Motoyama T, Aizawa K, Watanabe H, et al. Alpha-Fetoprotein pro ducing gastric carcinomas: a comparative study of three different subtypes[J]. Acta Pathol Jpn, 1993, 43(11): 654-61. [4] Chang YC, Nagasue N, Abe S, et al. Comparison between the clini copathologic features of AFP-positive and AFP-negative gastric cancers[J]. Am J Gastroenterol, 1992, 87(3): 321-5. [5] Ooi A, Nakanishi I, Sakamoto N, et al. Alpha-fetoprotein(AFP)-producing gastric carcinomas: is it hepatoid differentiation [J]? Cancer, 1990, 65(8): 1741-7. [6] Shimada S, Hayashi N, Marutsuka T, et al. Irinotecan plus low-dose cisplatin for alpha-fetoprotein-producing gastric carcinoma with multiple liver metastases: report of two cases[J]. Surg Today, 2002, 32(12): 1075-80. [7] 李有柱,吴晓瑞.产甲胎蛋白胃癌一例报告[J].白求恩医科大学学报(J Bethune Univ Med Scie),1997,23(1):93-4. [8] 陈杨弟.产甲胎蛋白胃癌[J].实用肿瘤杂志(J PracOncology),1994,9(4):235-6. |